TMS therapy for depression and OCD is FDA-cleared and covered by most insurance plans. Learn More
Active Path is pleased to announce that we have been selected by the Portland Business Journal as the 14th fastest growing company in Oregon and SW Washington. We are honored to be selected as one...
BURLINGTON, Mass. Aug. 18, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for...
Active Path’s Chief Medical Officer, Dr. Pritham Raj, joined KOIN AM Extra to discuss obsessive-compulsive disorder (OCD), common misconceptions, and TMS as a breakthrough treatment. Dr. Raj...
People struggling with severe depression may discover a valuable option in FDA-approved treatment By Raymond Rendleman, Clackamas Review Having opened its fifth location on Oct. 19 in...
